Continuous Glucose Monitoring

Continuous Glucose Monitoring (CGM) provides the complete picture by revealing lows and highs that HbA1C and fingerstick testing alone cannot always identify.


  • What continuous glucose monitoring is and how it can help you

If you are using the CGM features of your pump, you can see your glucose levels 24 hours a day. The pump, when combined with the Guardian 2 Link transmitter and the New Generation Enlite glucose sensor, wirelessly transmits readings to your MiniMed® 640G. The readings are updated every five minutes and appear on the screen in colour. These regular updates can give you a clear understanding of how your glucose is behaving and reduce your dependence on fingersticks*. You only need to change your glucose sensor every 6 days.

If you are on multiple daily injections, you can also benefit from CGM by using the Guardian® REAL-Time CGM, our stand-alone CGM monitor.


The advantages of CGM over traditional fingersticks and HbA1c testing are well-documented. Research has shown that:

  • 60% of glucose lows may not be revealed with fingersticks alone1
  • CGM identifies four times as many serious glucose excursions as self-monitoring of blood glucose (SMBG)2
  • CGM can significantly reduce HbA1c and has been shown to reduce  HbA1c levels by up to 1% when compared with fingerstick testing alone 3
  • CGM is proven to be accurate in numerous published studies enabling you to make therapy adjustments based on reliable data


The anecdotal and real-life stories from patients using CGM are overwhelming and includes:

  • Parents who can relax and no longer feel that they have to check on their child through the night
  • Sports enthusiasts and students who can concentrate on competing or taking their exams without worrying
  • People with busy work lives who can be as busy as they like and get on with their day-to-day activities with less anxiety
  • Women who are pregnant or are thinking about becoming pregnant

CGM has given people insights that they have never had before. With the establishment of the National Institutes for Health and Care Excellence (NICE) guidance for pump therapy, access to CGM is improving every day. NICE has also published guidance on continuous glucose monitoring in adults & children. Take a look at these so you can discuss this fully with your healthcare team.


We would like everyone that could benefit from CGM to have the opportunity to use it. For those patients who experience challenges with regard to CGM funding, self-funding is an option and we offer CGM Loyalty Schemes for our MiniMed pumpers- Learn more

Your MiniMed® 640G pump is 'CGM-ready', so you may decide to fund CGM when you first receive your pump, or you can start any time at a later date. There are many options available.

All you need to get started is a CGM starter kit with Guardian 2 Link transmitter, Guardian 2 Link Charger, 5 New Generation Enlite sensors and Serter. 

Just call our Customer Services Team to place an order or to ask for pricing information on:

01923 205 167 (press option 2)

Here are the order codes you'll beed for your CGM starter kit:

MiniMed 640G users:

Guardian 2 Link starter kit : (Guardian 2 Link transmitter, Guardian 2 Link Charger, 5 New Generation Enlite sensors and Serter): BNGBMM640GSSK1

For subsequent orders you will only need to order the Enlite glucose sensors: MMT-7008A

MiniMed Veo users:

New Generation Enlite starter kit (5 New Generation Enlite sensors Enlite sensors, MiniLink and Enlite serter): BNENLITESTART1001

For subsequent orders you will only need to order the Enlite glucose sensors: MMT-7008A


You will need to wear a small glucose sensor that sits under the skin for up to 6 days at a time. Just like an infusion set cannula, the sensor is easily inserted using an automatic device provided with the system. 85% Of patients agreed that insertion with New Generation Enlite was pain free**. The sensor attaches to a small lightweight transmitter** that sends glucose sensor data wirelessly to your insulin pump or a CGM stand-alone monitor through advanced radio frequency (RF) wireless technology.

The insulin pump or CGM monitor displays the glucose data On Screen and plots a Trend Line of the data so that you can see exactly what your glucose trends are and what may be affecting them.

As well as seeing the on-screen display, you can set Alerts on the insulin pump that will sound or vibrate to warn you when you are likely to reach, are reaching or have reached your glucose target limits. Having this information can help you to avoid hypo- or hyperglycaemic excursions, remain within your target glucose levels and help to reduce your HbA1C and achieve better control.


  • 1Pitzer KR, Desai S, Dunn T, et al. Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care. 2001;24(5):881-885.
  • 2Kaufman FR, et al. Diabetes Care. 2001;24(12):2030-2034
  • 3Raccah D, Sulmont V, Resnik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend Study. Diabetes Care. 2009;32(12):2245-2250
  • * This data is intended to supplement, not replace, blood glucose information obtained using standard home blood glucose monitoring devices. Fingersticks are required when adjusting insulin delivery and for calibrating the glucose sensor. Values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a meter blood glucose measurement may be required. All therapy adjustments should be based on measurements obtained using a home glucose meter and not on CGM system values.
  • ** Internal date on file; Medtronic MiniMed, Inc

Guardian™ 2 Link transmitter is only compatible with MiniMed® 640G insulin pump

MiniLink™ transmitter is compatible with MiniMed Paradigm® Veo™ system and Guardian® REAL-Time CGM system


The content and all information provided on this website is for your informational use only and is not intended to be a substitute for professional medical advice, diagnosis or treatment in any manner. The patient stories provided are experiences specific to a particular patient. Responses to a treatment may vary from patient to patient. Always talk with your physician about diagnosis and treatment information and ensure that you understand and carefully follow that information.

© 2016 Medtronic International Trading Sarl™. All Rights Reserved. No part of this website may be reproduced or utilized in any form or by any means without permission from Medtronic International Trading Sarl. MiniMed, Bolus Wizard, SMARTGUARD, Guardian, Enlite and CareLink are trademarks of Medtronic, Inc. and its subsidiaries. CONTOUR is a trademark of Ascensia Diabetes Care.